$67B Cigna-Express Scripts deal approved by final regulator

Amy Baxter | | Health Exec | Policy & Regulations

Cigna received its final approval from regulators for its $67 billion acquisition of Express Scripts. New Jersey approved the transaction, clearing the way for the deal to close, according to a public filing from Cigna.

“All required regulatory approvals now have been received and the parties expect to close the transaction on December 20, 2018, subject to the satisfaction of all other closing conditions,” the filing reads.

The transaction brings together a major health insurance provider with one of the nation’s largest pharmacy benefit managers. California and New York approved the deal on Dec. 13, but New Jersey remained as the last holdout.

The completion of the merger was originally anticipated to close by Dec. 8, but Cigna executives signaled the deal would be delayed in late November.

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

A modest proposal to rally AI regulators around a simple game plan
FDA set to ban certain over-the-counter cold medications
FDA commissioner urges clinicians to join fight against medical misinformation
Looming fear of more IV shortages as Hurricane Rafael gains strength
Walgreens settles class-action fraud lawsuit for $100M
Boston Medical Center installs solar panels to pay patients’ electric bills

Around the web

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

AI in Healthcare
4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Design by Adaptive Theme
Trimed Popup
Trimed Popup